MedPath

Investigating the Effects of Cardiac Rehabilitation eXercise Modalities on Physical and Mental Health Outcomes

Not Applicable
Completed
Conditions
Coronary Artery Disease (CAD)
Interventions
Behavioral: Moderate Intensity Continuous Exercise Training
Behavioral: Nordic Walking
Behavioral: High Intensity Interval Training
Registration Number
NCT02765568
Lead Sponsor
Ottawa Heart Institute Research Corporation
Brief Summary

Coronary revascularization improves survival for patients with coronary artery disease. However,many patients are left with poor physical and mental health. Traditional cardiac rehabilitation involves moderate intensity continuous exercise (MICE). Alternatives to traditional cardiac rehabilitation programming may however provide superior understudied benefits to patients with poor physical and mental health. Nordic walking (NW) and high-intensity interval training (HIIT) are two examples of alternative programs for cardiac rehabilitation, which may provide superior physical and mental health benefits when compared to traditional MICE. The main purpose of this project is, therefore, to determine the short and long term physical and mental health benefits of alternative cardiac rehabilitation modalities, including NW and HIIT on exercise capacity, quality of life and depression after a 12-week program.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
135
Inclusion Criteria
  • Patient with CAD who recently underwent PCI (within 2-10 weeks) PCI or coronary artery bypass grafting (within the last 18 weeks);
  • Patient is referred to University of Ottawa Heart Institute cardiac rehabilitation program;
  • Patient is able to walk independently
  • Patient is willing to attend an onsite cardiac rehabilitation program twice weekly for 12 weeks;
  • At least 40 years of age;
  • Patient is willing and able to provide informed consent
Exclusion Criteria
  • Currently participating in routine exercise training (>2x/week) and/or using Nordic Walking poles;
  • Active infection or inflammatory condition;
  • Over 75 years of age;
  • Persistent or permanent atrial fibrillation;
  • Pregnant, lactating or planning to become pregnant during the trial period;
  • Unstable angina or established diagnosis of chronic obstructive pulmonary disease, severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy;
  • Unable to read and understand English or French;
  • Unwilling or unable to return for follow-up visit at weeks 12 and 26;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Moderate Intensity Continuous ExerciseModerate Intensity Continuous Exercise TrainingModerate Intensity Continuous Exercise Training
Nordic WalkingNordic WalkingNordic Walking
High Intensity Interval TrainingHigh Intensity Interval TrainingHigh Intensity Interval Training
Primary Outcome Measures
NameTimeMethod
Exercise CapacityBaseline to 12 weeks and Baseline to 26 weeks

Changes in exercise capacity from baseline to 12 weeks and baseline to 26 weeks are measured by the six-minute walk test

Secondary Outcome Measures
NameTimeMethod
Functional FitnessBaseline to 12 weeks and Baseline to 26 weeks

Changes in functional fitness from baseline to 12 weeks and baseline to 26 weeks are measured by the Senior Fitness Test

Aortic stiffnessBaseline to 12 weeks and Baseline to 26 weeks

Changes in aortic stiffness from baseline to 12 weeks and baseline to 26 weeks are measured by pulse wave velocity

DepressionBaseline to 12 weeks and Baseline to 26 weeks

Changes in depression from baseline to 12 weeks and baseline to 26 weeks are measured by the Beck Depression Inventory-II questionnaire

Quality of Life - HeartQoLBaseline to 12 weeks and Baseline to 26 weeks

Changes in quality of life from baseline to 12 weeks and baseline to 26 weeks are measured by the HeartQoL questionnaire

Exercise AdherenceBaseline to 12 weeks and Baseline to 26 weeks

Changes in exercise adherence from baseline to 12 weeks and baseline to 26 weeks are measured by the Actigraph accelerometer

Body CompositionBaseline to 12 weeks and Baseline to 26 weeks

Changes in body composition from baseline to 12 weeks and baseline to 26 weeks are measured by body mass index.

Quality of Life - SF36Baseline to 12 weeks and Baseline to 26 weeks

Changes in quality of life from baseline to 12 weeks and baseline to 26 weeks are measured by the Short Form-36.

Depression mechanismsBaseline to 12 weeks and Baseline to 26 weeks

Changes in depression mechanisms from baseline to 12 weeks and baseline to 26 weeks are measured by plasma kynurenine.

Lipid and glucose profileBaseline to 12 weeks and Baseline to 26 weeks

Changes in lipid and glucose profile from baseline to 12 weeks and baseline to 26 weeks are measured by plasma Hemoglobin A1c

Trial Locations

Locations (1)

University of Ottawa Heart Insititue

🇨🇦

Ottawa, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath